Ambulatory Infusion Pumps Market (Product Type - Implantable Infusion Pumps, Volumetric Pumps, Syringe Infusion Pump, Enteral Infusion Pumps, and Others; Application - Chemotherapy, Oncology, Gastroenterology, Pediatrics and Neonatology, Hematology, Analgesia and Pain Management, and Others; End User - Hospitals, Ambulatory Surgery Centers, and Home Care and Outpatient Settings): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

A recent report published by Infinium Global Research on the ambulatory infusion pumps market provides an in-depth analysis of segments and sub-segments in the global as well as regional ambulatory infusion pumps market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional ambulatory infusion pumps market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global ambulatory infusion pumps market. According to the report, the global ambulatory infusion pumps market is projected to grow at a CAGR of 6.2% over the forecast period of 2021-2027. 

Market Insight

Ambulatory Infusion Pump (AIP) is a battery-powered device that slowly delivers medications and drugs directly to a patient. These pumps are used in a variety of medical settings including primary arterial, epidural, and intravenous (IV) infusions. Many different models and sizes are available, each designed for specific treatments. The main benefit of using an AIP is that it allows patients to receive continuous medication outside of traditional medical settings, granting them greater freedom and flexibility. These pumps improve life by letting patients keep up with their daily routines while getting the treatments they need. This reduces hospital stays and healthcare costs while giving patients more freedom and comfort. The market for ambulatory infusion pumps is expanding at a steady pace because of the increasing number of patients with long-term illnesses. Moreover, technological advancements in wireless connectivity of these pumps coupled with compact sizes are enhancing the efficiency of these pumps. Further, user-friendly features of these products is expected to boost the consumption of the infusion pumps in the years to come. 

The rise in the geriatric population worldwide is expected to support the growth in the demand for ambulatory infusion pumps. According to the United Nations, the demographic shift indicates that the segment of the population aged 65 years and older is likely to have higher share in the total population as compared to those below that age bracket. Consequently, projections suggest that the proportion of the global population aged 65 and above will increase from 10% in 2022 to 16% by 2050. With an aging population, there’s a growing demand for convenient and efficient healthcare solutions, including ambulatory infusion pumps which allow patients to receive medication outside of traditional medical settings. These pumps enable elderly individuals to manage chronic conditions or undergo treatments with greater flexibility and independence, contributing to their overall well- being. As healthcare systems are focusing on accommodating the needs of aging populations, the demand for ambulatory infusion pump experiences significant growth. This growth is also driven by the imperative to provide accessible and patient-cantered care to seniors. Additionally, increasing technological advancements in infusion pump systems drive the growth of the market. Technology is transforming ambulatory infusion pumps. New advancements make them smaller, last longer, and include smart features such as wireless connections. These changes make pumps easier to carry and use and can help patients stick to their treatment plans and get better results. However, cost concerns related to patients and healthcare facilities may potentially hamper the market’s growth. Nevertheless, the rising incidence of chronic illness creates a lucrative opportunity for growth in the market. 

Geographically, North America is expected to hold the largest market share in terms of revenue over the forecast period. The region boasts a strong healthcare infrastructure and high healthcare expenditure, facilitating sizeable adoption of advanced medical technology. The United States continued to maintain the highest ratio of health expenditure to GDP, standing at 16.6% in 2022. Additionally, North America has a huge population of sufferers requiring long-term medication management, including people with continual diseases and cancer. The presence of prominent market manufacturers such as Becton, Dickinson and Company, Baxter International Inc., and others drives market growth. Moreover, The Asia Pacific region emerges as the fastest-growing market for ambulatory infusion pumps due to several factors. Firstly, rapid urbanization and enhanced healthcare infrastructure in countries such as China, India, and Japan are expanding to get entry to superior medical technologies. Along with this, the rising incidence of chronic diseases within the region, coupled with an aging populace, drives a call for non-stop medicine administration out of the doors of conventional healthcare settings. Overall, these dynamics create a favourable environment for the rapid expansion of the ambulatory infusion pumps market within the Asia Pacific region. 

Segment Covered

The report on the global ambulatory infusion pumps market covers segments such as product type, application, and end user. On the basis of product type, the sub-markets include implantable infusion pumps, volumetric pumps, syringe infusion pump, enteral infusion pumps, and others. On the basis of application, the sub-markets include chemotherapy, oncology, gastroenterology, pediatrics and neonatology, hematology, analgesia and pain management, and others. On the basis of end user, the sub-markets include hospitals, ambulatory surgery centers, and home care and outpatient settings. 

Companies Profiled:

The report provides profiles of the companies in the market such as Becton, Dickinson and Company, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, ICU Medical Inc., Smiths Group Plc., Hospira Inc., Sorenson Medical Products Inc., and Zyno Medical LLC. 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the ambulatory infusion pumps market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.